DrugPatentWatch Database Preview
Patent: 5,854,231
» See Plans and Pricing
Summary for Patent: 5,854,231
| Title: | Pharmaceutical composition for inhibiting the growth of cancers |
| Abstract: | This invention is a pharmaceutical composition that inhibits the growth of cancers and tumors in mammals, particularly in human and warm blooded animals. The composition contains N-phosphonoglycine derivatives which are systemic herbicides in combination with chemotherapeutic agents for treatment of cancers and tumors. N-phosphonoglycine derivatives can be used to treat viral infections, particularly herpes infections. Optionally potentiators can be included. |
| Inventor(s): | Camden; James Berger (West Chester, OH) |
| Assignee: | The Procter & Gamble Company (Cincinnati, OH) |
| Application Number: | 08/680,469 |
| Patent Claims: | see list of patent claims |
Details for Patent 5,854,231
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Merck | ELSPAR | asparaginase | VIAL | 101063 | 001 | 1978-01-10 | Start Trial | The Procter & Gamble Company (Cincinnati, OH) | 2015-04-12 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 5,854,231
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Africa | 962880 | Start Trial |
| World Intellectual Property Organization (WIPO) | 9632115 | Start Trial |
| United States of America | 5665713 | Start Trial |
| United States of America | 5902804 | Start Trial |
| United States of America | 6090796 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
